Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients.
Supraspinal control of automatic postural responses in people with multiple sclerosis.
Infection.
Pre-clinical disease activity in multiple sclerosis- a prospective study on cognitive performance prior to first symptom.
Lumican negatively controls the pathogenicity of murine encephalitic TH17 cells.
Genome-Wide Transcriptional Profiling and Structural Magnetic Resonance Imaging in the Maternal Immune Activation Model of Neurodevelopmental Disorders.
Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus.
A high-fat diet fed during different periods of life impairs steroidogenesis of rat Leydig cells.
CD8+ phagocyte recruitment in rat experimental autoimmune encephalomyelitis: association with inflammatory tissue destruction.
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.
Candida utilis and Cyberlindnera (Pichia) jadinii: yeast relatives with expanding applications.
Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acids.
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.
Pediatric transverse myelitis.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
SLE Neuropathy-Anything New?
Transverse myelitis-like presentation of methanol intoxication: A case report and review of the literature.
Early hematopoiesis in multiple sclerosis patients.
Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups.
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis.
Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology.
A 17-Year-Old Girl With Acute Onset of Hemiparesis.
Acute ganglion cell loss during rapid visual recovery in optic neuritis.
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
Pages
« first
‹ previous
…
756
757
758
759
760
761
762
763
764
…
next ›
last »